This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Ratiopharm Gmbh. Active years: 2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012
**Title: The Innovative Contributions of Parshwakumar V. Kalyankar in Pharmaceutical Science**
Introduction
Parshwakumar V. Kalyankar is an accomplished inventor based in Goa, India, known for his innovative contributions to the pharmaceutical industry. His research and developments focus on enhancing the efficacy of pharmaceutical compounds, particularly in the area of drug formulation.
Latest Patents
Among his notable achievements, Parshwakumar holds a patent for "Escitalopram and solid pharmaceutical composition comprising the same." This invention pertains to Escitalopram, which features a small median particle size, therefore improving its effectiveness. The solid pharmaceutical composition developed by him has significant implications for enhancing the administration of this compound in therapeutic settings.
Career Highlights
Parshwakumar is currently associated with Ratiopharm GmbH, a prominent company in the pharmaceutical sector. His work within the company highlights his commitment to advancing medical science through innovative solutions. His patent is a testament to his expertise and dedication in the field.
Collaborations
Throughout his career, Parshwakumar has collaborated with various professionals in the industry. Notably, he has worked alongside esteemed colleagues such as Ganesh Vinayak Gat and Jawed Hussain. These collaborations foster a rich environment for innovation and contribute to the development of groundbreaking pharmaceutical products.
Conclusion
Parshwakumar V. Kalyankar is a key figure in the realm of pharmaceutical innovation, with his patent for Escitalopram illustrating his influential role. His work at Ratiopharm GmbH and collaborations with skilled professionals signify his commitment to advancing healthcare solutions. As a dedicated inventor, he continues to shape the future of drug development through his innovative ideas and research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
